Animal models to study the interplay between cancer and obesity

Adipose tissue and cancer

Volumn , Issue , 2013, Pages 99-119

  Ray, Amitabha ^a   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929527263     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-7660-3_6     Document Type: Chapter

References (94)

1. Basen-Engquist K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep. 2011;13:71-6.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-91.
3. Pisch on T, Nöthlilngs U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008;67:128-45.
4. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an infl ammatory issue. Ann N Y Acad Sci. 2011;1229:45-52.
5. Lysaght J, van der Stok EP, Allott EH, et al. Pro-infl ammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett. 2011;312:62-72.
6. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
7. Frederich RC, Hamann A, Anderson S, et al. Leptin levels refl ect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med. 1995;1:1311-4.
8. Wolff GL, Roberts DW, Mountjoy KG. Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics. 1999;1:151-63.
9. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216:28-43.
10. Grossm ann ME, Ray A, Nkhata KJ, et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010;29:641-53.
11. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66:33-8.
12. Heston WE, Vlahakis G. Infl uence of the A y gene on mammary-gland tumors, hepatomas, and normal growth in mice. J Natl Cancer Inst. 1961;26:969-83.
13. Heston WE, Vlahakis G. C3H-A vy-A high hepatoma and mammary tumor strain of mice. J Natl Cancer Inst. 1968;40:1161-6.
14. Wolff GL, Medina D, Umholtz RL. Manifestation of hyperplastic alveolar modules and mammary tumors in "viable yellow" and non-yellow mice. J Natl Cancer Inst. 1979;63:781-5.
15. Wolff GL, Kodell RL, Cameron AM, et al. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (A vy/A) (BALB/c X vy ) F1 hybrid mice. J Toxicol Environ Health. 1982;10:131-42.
16. Heston WE, Vlahakis G. Genetic obesity and neoplasia. J Natl Cancer Inst. 1962;29:197-209.
17. Cleary MP, Phillips FC, Getzin SC, et al. Genetically obese MMTV-TGF-?/Lep ob Lep ob mice do not develop of mammary tumors. Breast Cancer Res Treat. 2003;77:205-15.
18. Cleary MP, Juneja SC, Phillips FC, et al. Leptin receptor defi cient MMTV-TGF-?/Lepr db Lepr db femal e mice do not develop oncogene-induced mammary tumors. Exp Biol Med. 2004;229: 182-93.
19. Lee WM,Lu S,Medline A,et al. Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosurea Cancer Lett. 2001,162:155-60.
20. Hakkak R, Holley AW, MacLeod SL, et al. Obesity promotes 7, 12-dimethylbenz(a)anthraceneinduced mammary tumor development in female Zucker rats. Breast Cancer Res. 2005;7: R627-33.
21. Klurfeld DM, Lloyd LM, Welch CB, et al. Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med. 1991;196:381-4.
22. Waxler SH, Tabar P, Melcher LP. Obesity and the time of appearance of spontaneous mammary carcinoma in C3H mice. Cancer Res. 1953;13:276-8.
23. Nkhata KJ, Ray A, Dogan S, et al. Mammary tumor dev elopment from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements. Breast Cancer Res Treat. 2009;114:71-83.
24. Hu X, Juneja SC, Maihle NJ, et al. Leptin-A growth factor for normal and malignant breast cells and normal mammary gland development. J Natl Cancer Inst. 2002;94:1704-11.
25. Laud K, Gourdou I, Pessemesse L, et al. Identifi cation of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol. 2002; 188:219-26.
26. Waxler SH, Leef MF. Augmentation of mammary tumors in castrated obese C3H mice. Cancer Res. 1966;26:860-2.
27. Pariza MW. Fat, calories, and mammary carcinogenesis: net energy effects. Am J Clin Nutr. 1987;45:261-3.
28. Welsch CW, House JL, Herr BL, et al. Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. J Natl Cancer Inst. 1990;82:1615-20.
29. Cl eary MP, Grande JP, Juneja SC, et al. Effect of dietary-induced obesity and mammary tumor development in MMTV-neu female mice. Nutr Cancer. 2004;50:174-80.
30. Cleary MP, Grande JP, Maihl e NJ. Effect of a high fat diet on body weight and mammary tumor latency in MMTV-TGF-? mice. Int J Obes Relat Metab Disord. 2004;28:956-62.
31. Dogan S, Hu X, Zhang Y, et al. Effects of high fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-? mice. Breast Cancer Res. 2007;9:R91.
32. Khalid S, Hwang D, Babichev Y, et al. Evidence for tum or promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Res Treat. 2010;122:647-59.
33. Núnez NP, Perkins SN, Smith NCP, et al. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer. 2008;60:534-41.
34. Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol. 1997;61:281-6.
35. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45:277-82.
36. Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with infl ammation and elevated aromatase expression in the mouse mammary gland. Canc er Prev Res (Phila). 2011;4: 329-46.
37. Sonnenschein EG, Glickman LT, Goldschmidt LT, et al. Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiol. 1991;133:694-703.
38. Alenza DP, Rutterman GR, Peña L, et al. Relation between habitual diet and canine mammary tumors in a case-control study. J Vet Intern Med. 1998;12:132-9.
39. Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23:6365-78.
40. Donohoe CL, Pidgeon GP, Lysaght J, et al. Obesity and gastrointestinal cancer. Br J Surg. 2010;97:628-42.
41. Freeman HJ. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment. Best Pract Res Clin Gastroenterol. 2004 18: 1167-75.
42. Hirose Y, Hata K, Kuno T, et al. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-/db/db mice. Carcinogenesis. 2004;25:821-5.
43. Ealey KN, Lu S, Archer MC. Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter. Mol Carcinog. 2008;47:667-77.
44. Bobe G, Bar rett KG, Mentor-Marcel RA, et al. Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer. 2008; 60:373-80.
45. Hayashi K, Suz uki R, Miyamoto S, et al. Citrus auraptene suppresses azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ/db/db mice. Nutr Cancer. 2007;58:75-84.
46. Miyamoto S, Yasui Y, Ohigashi H, et al. Dietary fl avonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem Biol Interact. 2010; 183:276-83.
47. Yasuda Y, Shimizu M, Shirakami Y, et al. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Cancer Sci. 2010;101:1701-7.
48. Raju J, Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor ? and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res. 2003;63:6595-601.
49. Weber RV, Stein DE, Kim J, et al. Obesity potentiates experimental colon cancer. Int J Obes. 1997;20:S85.
50. Cowey SL, Quast M, Belalcazar LM, et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer. 2005;103:2643-53.
51. Teraoka N, Mu toh M, Takasu S, et al. High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-A y mice. Int J Cancer. 2011;129:528-35.
52. Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA. 1994;91:8969-73.
53. Gravaghi C, Bo J, LaPerle KMD, et al. Obesity enhances gastrointestinal tumorigenesis in APC-mutant mice. Int J Obes. 2008;32:1716-9.
54. Ding S, McEntee MF, Whelan J, et al. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium. Nutr Cancer. 2007;58:153-61.
55. Algire C, Amrein L, Zakikhani M, et al. Metformin blocks the stimulative effect of a highenergy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer. 2010;17:351-60.
56. Yakar S, Nunez NP, Pennisi P, et al. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology. 2006;147:5826-34.
57. Wu Y, Brodt P, Sun H, et al. Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res. 2010;70:57-67.
58. Drew JE, Farquharso n AJ, Padidar S, et al. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol. 2007;293:G682-91.
59. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-38.
60. Qian Y, Fan J-G. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int. 2005;4: 173-7.
61. Waxler SH. Obesity and cancer susceptibility in mice. Am J Clin Nutr. 1960;8:760-6.
62. Yang S,Lin HZ,Hwang J,.et al Hepatic hyperplasia in noncirrhotic fatty livers: is obesityrelated hepatic steatosis a premalignant condition? Cancer Res. 2001, 61:5016-23.
63. Soga M, Hashimoto M, Kishimoto Y, et al. Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congeneic strain of fatty liver Shionogi (FLS) mice with the Lep ob gene. Exp Anim. 2010;59:407-19.
64. Hill-Baskin AE, Markiewski MM, Buchner DA, et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet. 2009;18:2975-88.
65. Wunderlich FT, Luedde T, Stinger S, et al. Hepatic NF-?B essential modulator defi ciency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc Natl Acad Sci USA. 2008;105:1297-302.
66. Park EJ, Lee JH, Yu G-Y, et al. Dietary and genetic obesity promote liver infl ammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197-208.
67. Lemke LB, Rogers AB, Nambiar PR, et al. Obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma. J Endocrinol. 2008;199:21-32.
68. Stauffer JK, Scarzello AJ, Anderson JB, et al. Coactivation of AKT and ?-catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res. 2011;71:2718-27.
69. Iatropoulos MJ, Duan JD, Jeffrey AM, et al. Hepatocellular proliferation and hepatocarcinogen bioactivation in mice with diet-induced fatty liver and obesity. Exp Toxicol Pathol. 2013;65:451-6.
70. Shimizu M, Sakai H, Shirakami Y, et al. Preventive effects of (?)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Prev Res (Phila). 2011;4: 396-403.
71. Amling CL. Relationship between obesity and prostate cancer. Curr Opin Urol. 2005;15: 167-71.
72. Cao Y, Ma J. Body mass index, prostate cancer-specifi c mortality, and biochemical recurrence: a systematic review and meta-Analysis. Cancer Prev Res (Phila). 2011;4:486-501.
73. De Nunzio C, Freedland SJ, Miano L, et al. The uncertain relationship be tween obesity and prostate cancer: an Italian biopsy cohort analysis. Eur J Surg Oncol. 2011;37:1025-9.
74. Fowke JH, Motley SS, Concepcion RS, et al. Obesity, body composition, and prostate cancer. BMC Cancer. 2012;12:23.
75. Llaverias G, Danillo C, Wang Y, et al. A Western-type diet accelerates tumor progression in an autochtonous mouse model of prostate cancer. Am J Pathol. 2010;177:3180-91.
76. Bonorden MJL, Grossmann ME, Ewing SA, et al. Growth and progression of TRAMP prostate tumors in relation to diet and obesity. Prostate Cancer. 2012;2012:543970.
77. Blando J, Moore T, Hursting S, et al. Dietary energy balance modulates prostate cancer progression in Hi-Myc mice. Cancer Prev Res (Phila). 2011;4:2002-14.
78. Ribeiro AM, Andrade S, Pihno F, et al. Prostate cancer cell proliferation and angiogenesis in different obese mice models. Int J Exp Pathol. 2010;91:374-86.
79. Lamarre NS, Ruggieri MR, Braverman AS, et al. Effect of obese and lean Zucker rat sera on human and rat prostate cancer ce lls: implications in obesity-related prostate tumor biology. Urology. 2007;69:191-5.
80. Dinkova-Kostova AT, Fahey JW, Jenkins SN, et al. Rapid body weight gain incrases the risk of UV radiation-induced skin carcinogenesis in SKH-1 hairless mice. Nutr Res. 2008;28: 539-43.
81. Sharma SD, Katiyar SK. Leptin defi ciency-induced obesity exacerbates ultraviolet B radiation induced cyclooxygenase-2 e xpression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol. 2010;244:328-35.
82. Yun JP, Behan JW, Heisterkamp N, et al. Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models. Cancer Prev Res (Phila). 2010;3:1259-64.
83. Yu W,Cline M,Maxwell LG,et al. Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten +/? mice Cancer Prev Res (Phila 2010, 3:1246-58.
84. Shors AR, Solomon C, McTiernan A, et al. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control. 2001;12:599-606.
85. Gallus S, Naldi L, Martin L, et al. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res. 2006;16:83-7.
86. Naldi L, Altieri A, Imberti G, et al. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study f rom Italy. Ann Epidemiol. 2005;15:545-50.
87. Dennis LK, Lowe JB, Lynch CF, et al. Cutaneous melanoma and obesity in the agricultural health study. Ann Epidemiol. 2008;18:214-21.
88. Pandley V, Vijaykumar MV, Ajay AK, et al. Diet-induced obesity increases melanoma progression: involvement of Cav-1 and FASN. Int J Cancer. 2012;130:497-508.
89. Brand on EL, Gu J-W, Cantwell L, et al. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther. 2009;8:1871-9.
90. Kushiro K, Núnez NP. Ob/ob serum promotes mesenchymal cell phenotype in B16BL6 melanoma cells. Clin Exp Metastasis. 2011;28:877-86.
91. Mori A, Sakurai H, Choo M-K, et al. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer. 2006;119:2760-7.
92. Zyromski NJ, Mathur A, Pitt HA, et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery. 2009;146:258-63.
93. White PB, True EM, Ziegler KM, et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg. 2010;14:1888-94.
94. Zhang Q, Shen Q, Celestino J, et al. Enhanced estrogen-induced proliferation in obese rat endometrium. Am J Obstet Gynecol. 2009;200:186.e1-8.